Microbial and xanthine dehydrogenase inhibitory activity of some flavones

Xanthine dehydrogenase (XDH) is responsible for the pathological condition called Gout. In the present study different flavones synthesized from chalcone were evaluated in vitro for their inhibitory activity. Inhibitory activity of flavones on XDH was determined in terms of inhibition of uric acid synthesis from Xanthine. The enzymatic activity was found maximum at pH 7.5 and temperature 40°C. The flavones 6-chloro-2-[3-(4–hydroxy-phenyl)-1-phenyl-1-H-pyrazol-4-yl]-chromen-4-one (F1) and 6-chloro-7methyl-2-[3-(4-chloro-phenyl)-1-phenyl-1-H-pyrazol-4-yl]-chromen-4-one(F2),were noncompetitive and competitive inhibitor with Ki values 1.1 and 0.22 respectively. The flavones (F1), (F2), 6-chloro-2-[3-(4-chloro-phenyl)-1phenyl-1-H-pyrazol-4-yl]-chromen-4-one(F3), 8-bromo-6-chloro-2-[3-(4-chloro-phenyl)-1-phenyl-1-H-pyrazol-4-yl]-chromen-4-one (F4), 2-[3-(4-hydroxy-phenyl)-1-phenyl-1-H-pyrazol-4-yl]-chromen-4-one (F5) and 6-methyl-2-[3-(4-hydroxy-phenyl)-1-phenyl-1-H-pyrazol-4-yl]-chromen-4-one (F6) were also screened for their antimicrobial activity, measured in terms of zone of inhibition. A broad spectrum antifungal activity was obtained against Trichoderma viridae, Candida albicans, Microsporum cannis, Penicillium chrysogenum and Fusarium moniliformae. In case of Aspergillus niger and Aspergillus flavous only spore formation was affected, while antibacterial activity was observed against Staphylococcus aureus, Bacillus subtilis and Serratia marsecens only. The flavones were further analyzed for quantitative structural activity relationship study (QSAR) by using PASS, online software to determine their Pa value. Toxicity and drug relevant properties were revealed by PALLAS software in terms of their molecular weight. Log P values were also studied. The result showed both the F1 and F2 flavones as antigout and therefore supports the development of novel drugs for the treatment of gout.

[1]  K. Rajagopalan,et al.  Purification and properties of chicken liver xanthine dehydrogenase. , 1967, The Journal of biological chemistry.

[2]  T H Maugh,et al.  Chemistry and biochemistry. , 1973, Science.

[3]  Michael H. Abraham,et al.  Linear solvation energy relationships. 23. A comprehensive collection of the solvatochromic parameters, .pi.*, .alpha., and .beta., and some methods for simplifying the generalized solvatochromic equation , 1983 .

[4]  R. Stewart,et al.  The inhibition of xanthine oxidase by 8-bromoxanthine. , 1984, The Journal of biological chemistry.

[5]  Toshimitsu Hayashi,et al.  The Crystal Structure of Scopadulcic Acid A from Paraguayan Crude Drug "Typychá Kuratú" (Scoparia dulcis) , 1988 .

[6]  A. Ventom,et al.  The isolation of demolybdo xanthine oxidase from bovine milk. , 1988, The Biochemical journal.

[7]  T. Hayashi,et al.  Inhibition of cow's milk xanthine oxidase by flavonoids. , 1988, Journal of natural products.

[8]  Á. Ravelo,et al.  Xanthine oxidase inhibitory activity of some Panamanian plants from Celastraceae and Lamiaceae. , 1995, Journal of ethnopharmacology.

[9]  J. Roberts,et al.  Xanthine oxidase/dehydrogenase is present in human placenta. , 1996, Placenta.

[10]  Wade H. Shafer,et al.  Chemistry and Biochemistry , 2009 .

[11]  K. Cimanga,et al.  Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. , 1998, Journal of natural products.

[12]  Hidetaka Kobayashi,et al.  Inhibition of xanthine oxidase by flavonoids. , 1999, Bioscience, biotechnology, and biochemistry.

[13]  S. Macura,et al.  Flavones and sesquiterpene lactones from Achillea atrata subsp. multifida: antimicrobial activity. , 1999, Journal of natural products.

[14]  G. Bartosz Free Radicals in Biology and Medicine , 2000 .

[15]  R. Tan,et al.  Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. , 2000, Journal of ethnopharmacology.

[16]  D F Brown,et al.  Quality assurance of antimicrobial susceptibility testing by disc diffusion. , 2001, The Journal of antimicrobial chemotherapy.

[17]  Li-Ming Zhou,et al.  Chalcones and flavonoids as anti-tuberculosis agents. , 2002, Bioorganic & medicinal chemistry.

[18]  E. Pai,et al.  An Extremely Potent Inhibitor of Xanthine Oxidoreductase , 2003, The Journal of Biological Chemistry.

[19]  D. Atmani,et al.  Physicochemical and kinetic properties of purified sheep's milk xanthine oxidoreductase. , 2004, Journal of dairy science.

[20]  J. Hancock,et al.  Role of Xanthine Oxidoreductase as an Antimicrobial Agent , 2004, Infection and Immunity.

[21]  K. Schønning,et al.  Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. , 2005, Journal of medicinal chemistry.

[22]  R. Eisenthal,et al.  Molecular characterization of human xanthine oxidoreductase: the enzyme is grossly deficient in molybdenum and substantially deficient in iron-sulphur centres. , 2005, The Biochemical journal.

[23]  S. Kadota,et al.  Xanthine oxidase inhibitors from the heartwood of Vietnamese Caesalpinia sappan. , 2005, Chemical & pharmaceutical bulletin.

[24]  R. Yunes,et al.  Antifungal Activity and Studies on Mode of Action of Novel Xanthoxyline‐Derived Chalcones , 2005, Archiv der Pharmazie.